TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 56 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,363,895 | +1014.0% | 748,068 | +133.0% | 0.00% | – |
| Q2 2023 | $212,197 | -33.1% | 321,025 | -19.2% | 0.00% | – |
| Q1 2023 | $317,034 | -80.4% | 397,485 | -44.3% | 0.00% | – |
| Q4 2022 | $1,613,770 | -19.3% | 714,057 | -31.1% | 0.00% | – |
| Q3 2022 | $1,999,000 | -48.7% | 1,035,649 | -1.0% | 0.00% | – |
| Q2 2022 | $3,894,000 | -72.8% | 1,046,490 | -52.3% | 0.00% | – |
| Q1 2022 | $14,300,000 | -59.5% | 2,193,703 | -27.7% | 0.00% | -100.0% |
| Q4 2021 | $35,334,000 | -37.2% | 3,032,963 | +0.4% | 0.00% | -50.0% |
| Q3 2021 | $56,269,000 | -10.5% | 3,021,969 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $62,897,000 | +37.0% | 2,966,771 | +31.2% | 0.00% | +100.0% |
| Q1 2021 | $45,905,000 | -22.4% | 2,261,245 | +1.4% | 0.00% | -50.0% |
| Q4 2020 | $59,181,000 | +43.6% | 2,229,816 | +21.1% | 0.00% | 0.0% |
| Q3 2020 | $41,226,000 | – | 1,840,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |